Botched late-term abortion spurs lawsuit in blue-state court: 'Horrific'
An anonymous woman filed a rare medical negligence lawsuit last week against an Illinois abortionist after a late-term abortion took a "horrific" turn when an emergency hospital visit revealed "half of a deceased pre-born human being" was found left inside her.
Chicago injury attorney Richard Craig filed the lawsuit on behalf of Jane Doe from Indiana, naming both the Champaign-based Equity Clinic and its founder, Dr. Keith Reisinger-Kindle, as defendants.
Craig told Fox News Digital in an interview Thursday he's "never been presented" with a case like this.
Defund 'Big Abortion' Industry That Thrived Under Biden, 150 Pro-life Groups Urge Congress
The suit alleges that during a 22-week abortion performed in April 2023, Reisinger-Kindle left parts of the fetus inside the woman's body, leading to severe complications. After the procedure, when the woman reported persistent cramping, Reisinger-Kindle allegedly advised her to take over-the-counter pain relievers and laxatives. She later underwent emergency surgery to remove the body parts. Doe is seeking damages for medical negligence and emotional distress.
"This is someone who performed an abortion that at 22 weeks of gestation – which at that point renders a two-day process – and then on the second day, when most of the work is done, at the culmination of his work, he entered a note, saying, these are his words, 'products of conception were visibly inspected and confirmed to be complete,'" Craig said. "That's his note. Well, clearly that didn't happen."
Read On The Fox News App
"When she presented to the emergency room two days later, they found what they described to be as a half of a pre-deceased fetus," Craig said. "And the films that are in the records actually suggests more like two-thirds. So, how could he say that he visibly inspected her?"
Doe, a mother of four, also alleged that Reisinger-Kindle refused to provide pertinent information to the attending surgeons without her consent.
In a medical report included in the lawsuit filings, an obstetrician/gynecologist asserts that Reisinger-Kindle "deviated from a reasonable standard of care" during the abortion by perforating the plaintiff's uterus and failing to recognize the injury.
Doge Must 'Defund' Planned Parenthood, Mike Pence's Watchdog Group Urges Musk
The report also states that Reisinger-Kindle "failed to adequately examine the fetal parts" after the procedure. According to the lawsuit, there was a hole in the woman's uterus roughly the size of a large coin. The report notes that if Reisinger-Kindle "performed an adequate exam of the remains, it should have been obvious that fetal parts were left behind."
In the aftermath of the Supreme Court's 2022 decision overturning Roe v. Wade and leaving it up to states to decide on abortion, Illinois has solidified its position as a haven for the procedure, enacting a series of legislative measures to shield both providers and out-of-state women seeking abortion services from lawsuits.
Feds Gave $700M To Planned Parenthood During Year Of Record Abortions
Reisinger-Kindle, who was featured in a Chicago Tribune article, was one of many providers who opened abortion clinics in the Midwest following the high court's ruling.
Craig – who said taking the case won't make him "any friends in Illinois" – also alleged Reisinger-Kindle didn't administer any pain-relief medication to the fetus, which would have stopped its heartbeat, prior to its dismemberment.
"The current laws would prevent me, for instance, from pursuing a claim against this doctor on behalf of the child for what had to be excruciating pain that the child underwent while he was being dismembered piece by piece, without any pain relief," Craig said. "And so those laws do, in fact, prevent me, or anybody from taking that position and seeking redress for that on the behalf of the child."
Fox News Digital has reached out to Reisinger-Kindle for comment but did not hear back by time of publication.Original article source: Botched late-term abortion spurs lawsuit in blue-state court: 'Horrific'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
39 minutes ago
- Yahoo
Here Are The 9 States Being Hit With The Latest Egg Recall
Egg price decreases have been slow to arrive at grocery stores nationwide. Over the past two months, prices have finally begun to cool and a multi-state salmonella outbreak is just the punctuation mark to months of relentless eggflation that weary consumers don't need. But, it's what they've got! According to an official FDA announcement on June 6, nearly 2 million dozen egg cartons are being pulled from shelves due to a mass salmonella contamination risk. As if consumers weren't feeling wary enough, the specific recalled product is 1.7 million dozen brown, cage-free, certified organic eggs -- health-centric buzzwords that make customers feel like they're purchasing a product they can trust. This latest salmonella outbreak risk exponentially compounds the growing issue of consumer trust in food safety. For the first time since October 2024, month-to-month dozen egg prices finally decreased from $6.23 in March to $5.12 in April -- a national average price which still remains at a historic high. Eggflation was due largely in part to a shortage caused by an avian flu outbreak, which makes this latest recall of millions of eggs feel somehow even worse. The outbreak traces back to August Egg Company, a California-based manufacturer. As of June 5, the CDC has reported 79 cases of illness spanning seven states. The affected eggs were sold at Walmart stores in nine states: Arizona, California, Illinois, Indiana, Nebraska, Nevada, New Mexico, Washington, and Wyoming, as well as several other grocery chains concentrated in California and Nevada. Read more: 12 Gluten-Free Pasta Brands, Ranked Worst To Best Twenty-one of the 79 ill consumers have been hospitalized, and the CDC estimates that the actual number of sickened people is much higher. Consumers reported becoming ill between February 24, 2025 and May 17, 2025. Luckily, as an exercise in reducing food waste on such a mass scale, the August Egg Company "immediately began diverting all eggs from the plant to an egg-breaking facility, which pasteurizes the eggs and kills any pathogens," per a statement from the company, as reported by the FDA. To stay safe, people who have recently purchased eggs from Walmart should check their cartons for sell-by dates between March 4, 2025 and June 19, 2025. Foodies who have purchased eggs from grocery chains Save Mart, FoodMaxx, Lucky, Smart & Final, Safeway, Raleys, Food 4 Less, or Ralphs should look for sell-by dates from March 4, 2025 to June 4, 2025. The packages of affected eggs will be printed with the plant code number P-6562 or CA5330 with the Julian Dates between 32 and 126. A full list of affected plant numbers and UPCs is included in the FDA report. Shoppers who spy any of the above details on their egg cartons are being instructed to return the product to its place of purchase for a full refund. To be safe, sanitize all surfaces with which the affected product might have come into contact. Read the original article on Tasting Table.
Yahoo
an hour ago
- Yahoo
Gilbane, F.A. Wilhelm top out $4.3B Indianapolis hospital
This story was originally published on Construction Dive. To receive daily news and insights, subscribe to our free daily Construction Dive newsletter. A joint venture of Providence, Rhode Island-based Gilbane Building Co. and Indianapolis-based F.A. Wilhelm topped out Indiana University Health's new downtown Indianapolis hospital, according to a May 27 Gilbane news release. The $4.3 billion, 2.1 million-square-foot hospital, announced in August 2020, will contain 864 inpatient rooms, 50 operating rooms and two helipads, according to Gilbane's project page. It will combine the health system's Methodist and University Hospitals, and is on track to finish in 2027, according to a June 2024 construction update. The medical project, initially budgeted at $1.6 billion, swelled to $4.3 billion in 2023. Growing construction costs of more than 20% of the initial budget and a height increase in the hospital's three bed towers to 16 stories initially increased it to $2.31 billion, according to a 2023 news release from the hospital network. Along with those construction costs, support buildings and other infrastructure — which include medical offices, parking garages and logistics space — tacked on an additional $1.98 billion to the project's price tag, per the news release. Combined, the inflated costs and additional work more than doubled the original budget. The hospital will also feature three clinical institutes for cancer, cardiovascular and neuroscience care, according to the hospital's project page. The complex will include bridges to the Capitol View medical office building, the Indiana University School of Medicine and the South Support Building, per Gilbane. At a lower level, below-grade tunnels will traverse from the hospital to the School of Medicine, South Support Building and central utility plant. 'Reaching the topping-out milestone is a proud moment for our entire team,' said Aaron Perry, Gilbane's project director, in the release. 'It reflects years of hard work, coordination, and a shared dedication to safety and quality.' Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
L'Oréal acquires a majority stake in British skincare brand Medik8
L'Oréal has acquired a majority stake in the UK's Medik8 as it seeks to expand its position in the skincare market, the French beauty giant confirmed on Monday. As part of the deal, private equity firm Inflexion will remain a minority shareholder, and the current management committee will also stay in their roles. The cost of the stake is officially undisclosed, although the Financial Times reported last week that the potential deal was worth around €1bn. L'Oréal's share price was roughly unchanged on the news. 'We are delighted to welcome Medik8 to the L'Oréal family,' said Cyril Chapuy, President of L'Oréal LUXE. 'As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' he added. L'Oréal has been seeking to capitalise on the boom in science-driven skincare, partly driven by social media influencers. Brands already under its 'Dermatological Beauty Division' include La Roche-Posay, Cerave, Vichy, Skinceuticals, and Skinbetter Science. Related L'Oréal acquires Galderma stake and targets the injectables market The Body Shop goes into administration, with hundreds of UK jobs at risk This unit brought in over €7bn in revenue in 2024, representing an almost 10% year-on-year rise, making it L'Oréal's fastest-growing division. Seeking to expand its portfolio, L'Oréal bought soap maker Aesop in 2023, and Korean beauty brand Dr.G in December. Last year, L'Oréal also acquired a 10% stake in skincare firm Galderma, as well as acquiring the beauty licence for Miu Miu. At the time of the Galderma deal, the French firm said it was 'increasingly investing in a more holistic approach, spanning the entire beauty routine' — thereby 'anticipating and intercepting the signs of skin ageing'. Medik8, founded in 2009, specialises in anti-ageing treatments and was bought by UK-based private equity firm Inflexion in 2021. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
